Ringing a Bell on the Final Day of Radiation Therapy in Improving the Memory of Distress in Cancer Patients
Are Last Impressions Lasting Impressions? Intervention of Ringing a Bell at the End of Cancer Treatment
3 other identifiers
interventional
82
1 country
1
Brief Summary
This clinical trial studies how well ringing a bell on the final day of radiation therapy works in improving the memory of distress in cancer patients. Ringing a bell on the final day of radiation therapy may improve the memory of how painful the treatment was.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 15, 2016
CompletedFirst Submitted
Initial submission to the registry
November 15, 2016
CompletedFirst Posted
Study publicly available on registry
November 22, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 15, 2018
CompletedOctober 7, 2025
April 1, 2020
2.3 years
November 15, 2016
October 2, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Distress memory scales as assessed by the 11-point Numeric Rating Scale
Patient baseline characteristics and treatment will be summarized in groups A and B. Repeated measures analysis of variance (ANOVA) will be used to compare distress memory scales between patients in group A and group B. A mixed regression model will be used to examine the effect of ringing the bell on the last day of radiotherapy on distress memory scales when considering covariates such as baseline patient characteristics, cancer type, radiotherapy total dose and duration, baseline distress scale, analgesic medication, disease recurrence status, optimism/pessimism personality and anxiety.
Up to 7 months
Secondary Outcomes (2)
Anxiety level as assessed by Generalized Anxiety Disorder 7 scale
Up to 7 months
Optimism-pessimism scores as assessed by the Life Orientation Test-Revised
Up to 7 months
Study Arms (2)
Group A (no bell after final radiation)
ACTIVE COMPARATORPatients undergo standard of care radiation therapy with or without chemotherapy.
Group B (ring bell after final radiation treatment)
EXPERIMENTALOn the final day of standard of care radiation therapy, patients ring a bell in the clinic.
Interventions
Ring bell after final radiation treatment
Ancillary studies
Eligibility Criteria
You may qualify if:
- Diagnosis of cancer
- Definitive radiation treatment with or without concurrent chemotherapy with curative intent; treatment prior to radiation therapy is acceptable (e.g. surgery, chemotherapy)
- Ability to understand and the willingness to sign a written informed consent; consents will be provided in English or Spanish
- Able to speak English or Spanish (questionnaires will be in English and Spanish)
You may not qualify if:
- Patients with either a malignant central nervous system (CNS)-primary cancer or with brain metastases; patients do not need to undergo brain imaging unless indicated per standard workup and management (e.g. advanced stage lung cancer receiving definitive therapy)
- Patients who will be receiving surgery or adjuvant chemotherapy within 1 month following radiation treatment
- Patients with widespread metastatic disease (\> 3 distant metastases); patients with oligometastatic disease (=\< 3 distant metastases) are allowed only if they are receiving definitive (curative) radiation therapy (RT) with or without chemotherapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Southern Californialead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
USC / Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Patrick Williams
University of Southern California
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 15, 2016
First Posted
November 22, 2016
Study Start
August 15, 2016
Primary Completion
November 15, 2018
Study Completion
November 15, 2018
Last Updated
October 7, 2025
Record last verified: 2020-04